Four months after emerging from bankruptcy, Endo is in transition again with the sudden departure of CEO Blaise Coleman. Tuesday, without providing a reason, the Dublin-based company revealed ...
Aug. 27, 2024 /CNW/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company"), a diversified specialty pharmaceutical company transforming insights into life-enhancing therapies, today announced that ...
Specialty pharmaceutical company Endo disclosed that Blaise Coleman will depart as president and chief executive officer on Thursday. Endo tapped Scott Hirsch to serve as interim CEO while a ...
Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company"), a diversified specialty pharmaceutical company transforming insights into life-enhancing therapies, today announced that the Board of Directors has ...